Vaccines

Stimuvax®

Overview Stimuvax® is a synthetic 25-amino acid sequence of the cancer-associated marker MUC-1 encapsulated in a specially designed liposomal delivery system. Liposomes, which are fat droplets smaller than red blood cells, are believed to enhance immune recognition of cancer cells. This investigational vaccine offers an innovative approach to treating cancer and potentially prolonging life. It is designed to induce a T-cell immune response to the cancer.